Vol 11, No 2 (2010)

Table of Contents

Editorial

Equity of access to innovative drugs and sustainability of pharmaceutical expenditure
Mario Eandi
PDF
53-54

Review (Economic Analysis)

Fungal infections today: size of the problem and focus on the initial cost of therapy with echinocandin
Mario Venditti
PDF
55-62
Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
Viola Sacchi, Orietta Zaniolo, Ignazio Olivieri
PDF
63-76
Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes
Simona Cammarota, Enrica Menditto, Daria Putignano, Anna Citarella
PDF
83-89
Economic evaluation of the use of saxagliptin in the treatment of type 2 diabetes in Italy
Marco Cristiani, Anna Citarella, Andrea Belisari, Guido Didoni, Lorenzo Giovanni Mantovani, Sabato Montella
PDF
103-115
Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy
Orietta Zaniolo, Sorrel E. Wolowacz, Lorenzo Pradelli
PDF
91-101

Original research

Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil
Luca Guidi, Mariano Alejandro Mignini
PDF
77-82